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Abstract
Objectives:  This study examined condom acquisition by persons in a hospital setting when single
versus assorted brand name condoms were provided.
Methods:  Condom receptacles were placed in exam rooms of two clinics. During Phase 1, a single
brand name was provided; for Phase 2, assorted brand names were added. Number of condoms
taken was recorded for each phase.
Results:  For one clinic there was nearly a two-fold increase in number of condoms taken (Phase
1 to Phase 2); for the second clinic there was negligible difference in number of condoms taken.
Conclusions:  The provision of assorted brand name condoms, over a single brand name, can
serve to increase condom acquisition. Locations of condoms and target population characteristics
are related factors.
Public health professionals promote condom use as a
means to prevent the spread of hepatitis B, HIV and oth-
er sexually transmitted diseases (STD) among drug users
and other persons at risk for these diseases [1,2,3]. Con-
dom distribution, a strategy for increasing condom avail-
ability, is a principal component of risk reduction
interventions targeting these persons and condom avail-
ability has been enhanced via the application of social
marketing principles [4,5,6].
With the establishment of effective condom distribution
systems, public health professionals are then challenged
to encourage the use of these systems by those at risk.
Condom distribution setting, condom cost and provision
of a variety of condoms are all factors that may influence
people to acquire condom [7,8,9,10,11].
There are a wide variety of condoms on the market, with
at least 70 types differing by brand name, size, texture,
thickness, color, flavor, scent, lubrication level and lubri-
cation type [12]. The range of condom properties offered
suggests that manufacturers are not only responsive to
matters related to condom utility, they are also seeking to
satisfy user's particular preferences. Among condom us-
ers, condom acceptability is influenced by characteristics
such as shape, size and amount of lubrication [13,14,15].
These and other potentially desirable characteristics can
vary from one brand name to another. The current study
examines condom acquisition when single versus assort-
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ed brand name condoms was made available to persons
within a hospital-based condom distribution system.
Methods
Setting and Procedures
This study was conducted from January to May of 1997
at the Alaska Native Medical Center located in Anchor-
age, Alaska. The medical center at the time of this study
was an Indian Health Service facility that provided
health care to Alaska Natives, American Indians and oth-
er non-Native American beneficiaries. Prior to beginning
this study, the Outpatient Pharmacy and Women's
Health Clinic distributed a single brand name condom,
offering the LifeStyles® lubricated condom, which is list-
ed in the General Services Administration formulary. For
this study, we established condom distribution locations
in the Internal Medicine Clinic (IMC; open weekdays, 8-
6 PM) and Emergency/Urgent Care Clinic (ECC; open 24
hours a day, 7 days a week).
Condom receptacles, open-topped clear plastic contain-
ers (4 ×  10 ×  7 in), were placed in 5 IMC and 6 ECC exam
rooms. Receptacles were wall-mounted with the opening
58 inches from the floor, an unreachable distance for
most children. Characteristics of the clinic exam rooms
(i.e., room size and furnishings) influenced placement of
the receptacles. Exam rooms in the IMC were large and
it was often necessary to mount receptacles amongst or
over existing furnishings. Exam rooms in the ECC were
small and contained few furnishings, allowing us to
mount receptacles in more accessible locations.
To familiarize patients with the new distribution loca-
tions, we provided LifeStyles® lubricated condoms for a
30-day period prior to beginning Phase 1. During the
study period, IMC and ECC receptacles were monitored
and replenished with condoms on a biweekly basis. In
addition, a supply of patient education pamphlets per-
taining to disease prevention and condom use tech-
niques was also maintained.
For Phase 1 (1/23/97 to 3/17/97; 54 days) receptacles
were filled with known quantities of LifeStyles® lubricat-
ed condoms. For Phase 2 (3/18/97 to 5/6/97; 50 days),
we continued providing LifeStyles® lubricated condoms
and added known quantities of assorted brand name
condoms, including Love Gasket®, Maxx Plus®, Ram-
ses®, Fiesta®, lubricated and mint-flavored Sheik®, Ki-
mono® and Gold Coin®.
Data Analysis
Clinic visits by patients age 14 years and younger were
excluded as we reasoned that a majority of them would
be less motivated or unable to take condoms. Hospital
computer records were reviewed to determine diagnostic
codes for patient encounters in each clinic. Paired sam-
ples t test and chi square analysis was used as appropri-
ate.
Results
Table 1 illustrates sex and age of patients and details of
patient diagnoses at encounter for the overall study peri-
od. During this time 6000 females and 3578 males were
seen at the IMC and ECC; patient sex was significantly
associated with clinic attendance (Χ 2 1 = 7.5, P = .006).
The mean age for females (39.8 years) was not signifi-
cantly different than that of males (40.2 years). Patients
seen at the ECC were significantly younger (mean = 37.9
years) than those seen at the IMC (mean = 49.3 years; t
9576 = -26.89, P < .001). Among IMC patients, diagnoses
at encounter were generally chronic or maintenance in
nature (e.g., hepatitis B carrier, diabetes) and visits
among ECC patients were generally acute or episodic
(e.g., trichomonas, drug intoxication). Encounters in-
volving drug or alcohol-related conditions were much
more common among ECC patients.
For the IMC there was slight increase in number of con-
doms taken from Phase 1 to Phase 2 (285 vs 286). For the
ECC there was nearly a two-fold increase in number of
condoms taken from Phase 1 to Phase 2 (3565 vs 6067).
Discussion
Study findings suggest that the provision of assorted
brand name condoms, over a singular brand name, will
serve to increase condom acquisition. Patients were of-
ten unattended in the exam rooms giving them opportu-
nity to take condoms in private, a condition shown to be
favorable to improving acquisition rates [7]. Substantial
increases in condom acquisition were, however, only ob-
served in the ECC. Previous research illustrates chronic
drug users and injection drug users visit emergency
rooms more often than nondrug users [16]. Indeed, in
the current study ECC patients were more likely than ICC
patients to have a drug or alcohol-related diagnosis. This
condition and the finding that ECC patients were signif-
icantly younger than ICC patients may be indicative of
increased sexual activity. Patients may have recognized
their sexual behaviors to be high-risk (i.e., for STD or
pregnancy); therefore condoms, especially when a varie-
ty of brand names were available for selection, were a
valued commodity. This suggestion is supported in part
by the data as ECC patients had more STD diagnoses that
were acute in nature.BMC Public Health (2001) 1:5 http://www.biomedcentral.com/1471-2458/1/5
Data from both study phases showed that ECC patients
acquired far more condoms than did IMC patients. The
IMC maintains daytime hours of operation on weekdays
and an appointment is generally required. In contrast,
the ECC is open 24-hours a day, seven days a week and
can be visited without an appointment. Thus, ECC pa-
tients had greater opportunity and possible intent, as the
data show they were much higher risk than IMC patients,
to acquire condoms. The higher number of condoms tak-
en from the ECC may also be attributable to condom re-
ceptacle placement. Receptacles in the ECC were highly
visible and accessible. However, receptacles in the IMC
were, in cases, located above equipment making access
potentially more difficult.
The offering of assorted brand name condoms may ap-
peal to persons in several ways. Merely the uniqueness of
the packaging (e.g., wrapper color or design), condom
brand name (e.g., Love Gasket® or Maxx Plus®), or con-
dom style (e.g., flavored or colored) may induce people to
take them. In addition, as previously stated, shape, size
and amount of lubrication can influence condom accept-
ability. Those who find these characteristics acceptable
may see them identified on the condom label or they may
infer them from the brand name. Lastly, people may
have familiarity with or loyalty to a particular brand
name or they may simply be interested in experimenting
with new ones.
An intended outcome of this study was the formation of
a strategy for improving condom accessibility and acqui-
sition, with the hopeful goal to increase their use, among
a population having members who demonstrate low
rates of condom use and high rates of sexually transmit-
ted disease [17,18,19]. Therefore, we did not attempt to
collect additional patient-specific data given concerns
that methods for doing so, such as, obtaining of informed
consent, conducting focused interviews and observing
condom taking behavior would negatively impact its po-
tential benefit. Consequently, we were unable to deter-
mine who took condoms and whether the condoms were
used, given away, or even sold or destroyed. In consider-
ation, we limited statistical analyses to patient demo-
graphics and number of condoms distributed. However,
we contend that the increased number of free condoms
taken from the hospital is likely to have resulted in in-
creased availability and usage in the community.
The intervention as described herein is currently not be-
ing offered at the hospital. This is due in part to a move
to a new hospital facility and departmental budget con-
siderations. However, condoms are available at no cost
through the hospital pharmacy and they can be taken
anonymously from several other clinics. Given the pa-
tient population and the high volume of patient visits,
the ECC is a key venue for condoms and we are develop-
ing a means to reintroduce a distribution system to this
clinic.
Results of our study suggest that programs maintaining
a condom distribution system should offer a variety of
brand name condoms to their participants. We note that
before beginning this study we conducted no research to
Table 1: Number of patient visits, patient demographics and pa-
tient diagnoses at encounter by clinic for the overall study period
Number of Pa-
tient Visits*
n (%)
Internal Medicine Clinic (IMC) 2444
Sex
Female 1043 (60)
Male 702 (40)
Age
14-28 228 (13)
29-43 457 (26)
44-58 506 (29)
59-73 400 (23)
74-88 148 (8)
≥  89 6 (<1)
Patient Diagnoses at Encounter
Liver, Heart or Other Internal Medicine Exam or 
Treatment (most frequent diagnoses)
642
Sexually Transmitted Disease (HIV 
and hepatitis B)
74
Drug or Alcohol-Related Condi-
tion†
145
Emergency/Urgent Care Clinic 
(ECC)
12 528
Sex
Female 4957 (63)
Male 2876 (37)
Age
14-28 2456 (31)
29-43 2945 (38)
44-58 1507 (19)
59-73 705 (9)
74-88 213 (3)
≥  89 7 (<1)
Patient Diagnoses at Encounter
Upper Respiratory Disorder (most 
frequent diagnosis)
1293
Sexually Transmitted Disease (gonorrhea, chlamydia, 
HIV, hepatitis B, trichomonas
and genital herpes) 38
Drug or Alcohol-Related Condi-
tion†
1004
*Values include multiple visits by a single patient. †Includes dependent 
and nondependent drug abuse, and alcohol dependence and intoxica-
tion.BMC Public Health (2001) 1:5 http://www.biomedcentral.com/1471-2458/1/5
support our decision to purchase and distribute one
brand name over another. However, we did have anecdo-
tal reports from female patients, who were known to
trade sex for money or drugs, that they preferred fla-
vored or nonlubricated condoms for oral sex. Thus, we
suggest that program administrators survey their target
population to evaluate the acceptability of particular
brand names or condom styles. Alternatively, programs
could closely monitor condom inventories and subse-
quently provide brand names that have higher demand.
Explicating the relationship between brand name prefer-
ence, condom distribution location and condom use is a
topic for future research.
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